Pfizer settles Protonix patent case for $2.15B
Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix.
Jun 12, 2013
0
0
Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix.
Jun 12, 2013
0
0
Pfizer Inc., in a first for the drug industry, told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.
May 6, 2013
0
0
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's expectations, and ...
Apr 30, 2013
0
0
Pfizer Inc. says its experimental pill for advanced, often deadly breast cancer has been designated as a breakthrough therapy by the Food and Drug Administration.
Apr 10, 2013
0
0
Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars ...
Mar 5, 2013
0
0
The U.S. Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that do not respond to other treatments.
Feb 25, 2013
0
0
Hot flashes put a damper on women's health and productivity at work and pump up the cost of health care. A study published online this month in Menopause, the journal of the North American Menopause Society (NAMS), has put ...
Feb 22, 2013
0
0
(AP)—The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed ...
Jan 31, 2013
0
0
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. The drugmaker's ...
Jan 29, 2013
0
0